25 related articles for article (PubMed ID: 4598805)
1. DRDB: A Machine Learning Platform to Predict Chemical-Protein Interactions towards Diabetic Retinopathy.
Wei Y; Zhang R; Li X; Li Z; Guo K; Li S; Yan L; Zhao Q; Qu B; Wang W; Zhou S; Sun H; Lin J; Hu Y
Oxid Med Cell Longev; 2022; 2022():1718353. PubMed ID: 35910835
[TBL] [Abstract][Full Text] [Related]
2. Calcium dobesilate reduces endothelin-1 and high-sensitivity C-reactive protein serum levels in patients with diabetic retinopathy.
Javadzadeh A; Ghorbanihaghjo A; Adl FH; Andalib D; Khojasteh-Jafari H; Ghabili K
Mol Vis; 2013; 19():62-8. PubMed ID: 23335852
[TBL] [Abstract][Full Text] [Related]
3. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
Ribeiro ML; Seres AI; Carneiro AM; Stur M; Zourdani A; Caillon P; Cunha-Vaz JG;
Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1591-600. PubMed ID: 16763797
[TBL] [Abstract][Full Text] [Related]
4. Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy.
Leite EB; Mota MC; de Abreu JR; Cunha-Vaz JG
Int Ophthalmol; 1990 Mar; 14(2):81-8. PubMed ID: 2187006
[TBL] [Abstract][Full Text] [Related]
5. The value of calcium dobesilate in the treatment of diabetic retinopathy. A controlled clinical trial.
Larsen HW; Sander E; Hoppe R
Diabetologia; 1977 Apr; 13(2):105-9. PubMed ID: 323093
[TBL] [Abstract][Full Text] [Related]
6. Effect of calcium dobesilate on blood viscosity in diabetic microangiopathy. A review.
Barras JP; Michal M
Vasa; 1986; 15(3):200-5. PubMed ID: 3532608
[No Abstract] [Full Text] [Related]
7. [Decrease of vascular fragility in diabetic retinopathy through calciumdobesilate (author's transl)].
Freyler H; Sehorst W
Klin Monbl Augenheilkd; 1974 Feb; 164(2):246-51. PubMed ID: 4842139
[No Abstract] [Full Text] [Related]
8. Calcium dobesilate as a treatment for capillary fragility in diabetic retinopathy.
Benarroch IS; de Salama Benarroch AR; Nano H; Perez H; Bisceglia H
Ophthalmologica; 1974; 168(5):370-5. PubMed ID: 4832044
[No Abstract] [Full Text] [Related]
9. [Treatment of the diabetic retinopathy with doxium-clofibrate (author's transl)].
Freyler H; Egerer I
Klin Monbl Augenheilkd; 1976 Mar; 168(3):377-86. PubMed ID: 787642
[TBL] [Abstract][Full Text] [Related]
10. The effect of calcium dobesilate on nonproliferative diabetic retinopathy: a controlled study.
Stamper RL; Smith ME; Aronson SB; Cavender JC; Cleasby GW; Fung WE; Becker B
Ophthalmology; 1978 Jun; 85(6):594-606. PubMed ID: 353623
[TBL] [Abstract][Full Text] [Related]
11. [Metabolism and pharmacokinetics of calcium dobesilate in humans].
Benakis A; Glasson B; Bouvier CA; Ritschard J; Krahenbuhl B; Jung A; Hachen HJ
Therapie; 1974; 29(2):211-9. PubMed ID: 4849166
[No Abstract] [Full Text] [Related]
12. Microvascular protection with calcium dobesilate (Doxium) in diabetic retinopathy.
Freyler H
Ophthalmologica; 1974; 168(5):400-16. PubMed ID: 4598805
[No Abstract] [Full Text] [Related]
13. [Calcium dobesilate].
Reuter H
Z Allgemeinmed; 1975 Feb; 51(6):292-3. PubMed ID: 1092080
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
